Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 401

    1.

    EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries.

    Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U; EUROASPIRE Study Group.

    Eur J Cardiovasc Prev Rehabil. 2009 Apr;16(2):121-37.PMID: 19287307 [PubMed - indexed for MEDLINE]Related articles

    2.

    Hyperglycemia and incidence of ischemic and hemorrhagic stroke-comparison between fasting and 2-hour glucose criteria.

    Hyvärinen M, Tuomilehto J, Mähönen M, Stehouwer CD, Pyörälä K, Zethelius B, Qiao Q; DECODE Study Group.

    Stroke. 2009 May;40(5):1633-7. Epub 2009 Mar 12.PMID: 19286584 [PubMed - indexed for MEDLINE]Related articles

    3.

    Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries.

    Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U; EUROASPIRE Study Group.

    Lancet. 2009 Mar 14;373(9667):929-40.PMID: 19286092 [PubMed - indexed for MEDLINE]Related articles

    4.

    Hyperglycemia and stroke mortality: comparison between fasting and 2-h glucose criteria.

    Hyvärinen M, Qiao Q, Tuomilehto J, Laatikainen T, Heine RJ, Stehouwer CD, Alberti KG, Pyörälä K, Zethelius B, Stegmayr B; DECODE Study Group.

    Diabetes Care. 2009 Feb;32(2):348-54. Epub 2008 Nov 18.PMID: 19017775 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    [European practice guidelines on prevention of cardiovascular diseases: executive summary]

    Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Reimer WS, Weissberg P, Wood D, Yarnell J, Zamorano JL; Quarta Task Force Congiunta della Società Europea di Cardiologia e; Società sulla Prevenzione delle Malattie Cardiovascolari nella Pratica Clinica (costituita da altre nove società ed esperti invitati).

    G Ital Cardiol (Rome). 2008 Jan;9(1):11-59. Italian. No abstract available. PMID: 18383763 [PubMed - indexed for MEDLINE]Related articles

    6.

    Prevalence of angina in women versus men: a systematic review and meta-analysis of international variations across 31 countries.

    Hemingway H, Langenberg C, Damant J, Frost C, Pyörälä K, Barrett-Connor E.

    Circulation. 2008 Mar 25;117(12):1526-36. Epub 2008 Mar 17. Review.PMID: 18347213 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Coronary events in persons aged 75 years or older in Finland from 1995 to 2002: the FINAMI study.

    Koukkunen H, Salomaa V, Lehto S, Ketonen M, Immonen-Räihä P, Lehtonen A, Havulinna A, Kesäniemi YA, Pyörälä K; FINAMI Study Group.

    Am J Geriatr Cardiol. 2008 Mar-Apr;17(2):78-86.PMID: 18326953 [PubMed - indexed for MEDLINE]Related articles

    8.

    Similarity of the impact of type 1 and type 2 diabetes on cardiovascular mortality in middle-aged subjects.

    Juutilainen A, Lehto S, Rönnemaa T, Pyörälä K, Laakso M.

    Diabetes Care. 2008 Apr;31(4):714-9. Epub 2007 Dec 14.PMID: 18083789 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).

    Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Op Reimer WS, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Altiner A, Bonora E, Durrington PN, Fagard R, Giampaoli S, Hemingway H, Hakansson J, Kjeldsen SE, Larsen L, Mancia G, Manolis AJ, Orth-Gomer K, Pedersen T, Rayner M, Ryden L, Sammut M, Schneiderman N, Stalenhoef AF, Tokgözoglu L, Wiklund O, Zampelas A; European Society of Cardiology (ESC); European Association for Cardiovascular Prevention and Rehabilitation (EACPR); Council on Cardiovascular Nursing; European Association for Study of Diabetes (EASD); International Diabetes Federation Europe (IDF-Europe); European Stroke Initiative (EUSI); Society of Behavioural Medicine (ISBM); European Society of Hypertension (ESH); WONCA Europe (European Society of General Practice/Family Medicine); European Heart Network (EHN); European Atherosclerosis Society (EAS).

    Eur J Cardiovasc Prev Rehabil. 2007 Sep;14 Suppl 2:S1-113. No abstract available. PMID: 17726407 [PubMed - indexed for MEDLINE]Related articles

    10.

    European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).

    Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Op Reimer WS, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Altiner A, Bonora E, Durrington PN, Fagard R, Giampaoli S, Hemingway H, Hakansson J, Kjeldsen SE, Larsen ML, Mancia G, Manolis AJ, Orth-Gomer K, Pedersen T, Rayner M, Ryden L, Sammut M, Schneiderman N, Stalenhoef AF, Tokgözoglu L, Wiklund O, Zampelas A; European Society of Cardiology (ESC); European Association for Cardiovascular Prevention and Rehabilitation (EACPR); Council on Cardiovascular Nursing; European Association for Study of Diabetes (EASD); International Diabetes Federation Europe (IDF-Europe); European Stroke Initiative (EUSI); International Society of Behavioural Medicine (ISBM); European Society of Hypertension (ESH); European Society of General Practice/Family Medicine (ESGP/FM/WONCA); European Heart Network (EHN).

    Eur J Cardiovasc Prev Rehabil. 2007 Sep;14 Suppl 2:E1-40. No abstract available. PMID: 17726406 [PubMed - indexed for MEDLINE]Related articles

    11.

    European guidelines on cardiovascular disease prevention in clinical practice: executive summary.

    Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Op Reimer WS, Weissberg P, Wood D, Yarnell J, Zamorano JL; ESC Committee for Practice Guidelines.

    Atherosclerosis. 2007 Sep;194(1):1-45. Epub 2007 Sep 18. No abstract available. PMID: 17880983 [PubMed - indexed for MEDLINE]Related articles

    12.

    European guidelines on cardiovascular disease prevention in clinical practice: executive summary.

    Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts), Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Scholte op Reimer W, Weissberg P, Wood D, Yarnell J, Zamorano JL; Other experts who contributed to parts of the guidelines:, Walma E, Fitzgerald T, Cooney MT, Dudina A; European Society of Cardiology (ESC) Committee for Practice Guidelines (CPG), Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Hellemans I, Altiner A, Bonora E, Durrington PN, Fagard R, Giampaoli S, Hemingway H, Hakansson J, Kjeldsen SE, Larsen ML, Mancia G, Manolis AJ, Orth-Gomer K, Pedersen T, Rayner M, Ryden L, Sammut M, Schneiderman N, Stalenhoef AF, Tokgözoglu L, Wiklund O, Zampelas A.

    Eur Heart J. 2007 Oct;28(19):2375-414. Epub 2007 Aug 28. No abstract available. PMID: 17726041 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Long-term prognosis after coronary artery bypass surgery.

    Ketonen M, Pajunen P, Koukkunen H, Immonen-Räihä P, Mustonen J, Mähönen M, Niemelä M, Kuulasmaa K, Palomäki P, Arstila M, Vuorenmaa T, Lehtonen A, Lehto S, Miettinen H, Torppa J, Tuomilehto J, Airaksinen J, Pyörälä K, Salomaa V; FINMONICA/FINAMI Study Group.

    Int J Cardiol. 2008 Feb 20;124(1):72-9. Epub 2007 Mar 26.PMID: 17383028 [PubMed - indexed for MEDLINE]Related articles

    14.

    Serum zinc level and coronary heart disease events in patients with type 2 diabetes.

    Soinio M, Marniemi J, Laakso M, Pyörälä K, Lehto S, Rönnemaa T.

    Diabetes Care. 2007 Mar;30(3):523-8.PMID: 17327315 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women.

    Juutilainen A, Lehto S, Rönnemaa T, Pyörälä K, Laakso M.

    Diabetes Care. 2007 Feb;30(2):292-9.PMID: 17259497 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD).

    Rydén L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, Cosentino F, Jönsson B, Laakso M, Malmberg K, Priori S, Ostergren J, Tuomilehto J, Thrainsdottir I, Vanhorebeek I, Stramba-Badiale M, Lindgren P, Qiao Q, Priori SG, Blanc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo J, Zamorano JL, Deckers JW, Bertrand M, Charbonnel B, Erdmann E, Ferrannini E, Flyvbjerg A, Gohlke H, Juanatey JR, Graham I, Monteiro PF, Parhofer K, Pyörälä K, Raz I, Schernthaner G, Volpe M, Wood D; Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC); European Association for the Study of Diabetes (EASD).

    Eur Heart J. 2007 Jan;28(1):88-136. No abstract available. PMID: 17220161 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Cardiovascular risk prediction systems have to be adapted and updated to current national conditions.

    Pyörälä K.

    Eur J Cardiovasc Prev Rehabil. 2006 Oct;13(5):674-5. No abstract available. PMID: 17001204 [PubMed - indexed for MEDLINE]Related articles

    18.

    Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes and the Heart.

    Bartnik M, Rydén L, Malmberg K, Ohrvik J, Pyörälä K, Standl E, Ferrari R, Simoons M, Soler-Soler J; Euro Heart Survey Investigators.

    Heart. 2007 Jan;93(1):72-7. Epub 2006 Aug 11.PMID: 16905628 [PubMed - indexed for MEDLINE]Related articles

    19.

    The effect of correcting for troponins on trends in coronary heart disease events in Finland during 1993-2002: the FINAMI study.

    Salomaa V, Ketonen M, Koukkunen H, Immonen-Räihä P, Lehtonen A, Torppa J, Kuulasmaa K, Kesäniemi YA, Pyörälä K; FINAMI Study Group.

    Eur Heart J. 2006 Oct;27(20):2394-9. Epub 2006 Jul 3.PMID: 16818460 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Proteinuria and metabolic syndrome as predictors of cardiovascular death in non-diabetic and type 2 diabetic men and women.

    Juutilainen A, Lehto S, Rönnemaa T, Pyörälä K, Laakso M.

    Diabetologia. 2006 Jan;49(1):56-65. Epub 2005 Dec 20.PMID: 16365726 [PubMed - indexed for MEDLINE]Related articles

    21.

    Type 2 diabetes as a "coronary heart disease equivalent": an 18-year prospective population-based study in Finnish subjects.

    Juutilainen A, Lehto S, Rönnemaa T, Pyörälä K, Laakso M.

    Diabetes Care. 2005 Dec;28(12):2901-7.PMID: 16306552 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Myocardial infarction in diabetic and non-diabetic persons with and without prior myocardial infarction: the FINAMI Study.

    Pajunen P, Koukkunen H, Ketonen M, Jerkkola T, Immonen-Räihä P, Kärjä-Koskenkari P, Kuulasmaa K, Palomäki P, Mustonen J, Lehtonen A, Arstila M, Vuorenmaa T, Lehto S, Miettinen H, Torppa J, Tuomilehto J, Kesäniemi YA, Pyörälä K, Salomaa V.

    Diabetologia. 2005 Dec;48(12):2519-24. Epub 2005 Oct 25.PMID: 16247597 [PubMed - indexed for MEDLINE]Related articles

    23.

    Smoking behaviour in European patients with established coronary heart disease.

    Scholte op Reimer W, de Swart E, De Bacquer D, Pyörälä K, Keil U, Heidrich J, Deckers JW, Kotseva K, Wood D, Boersma E.

    Eur Heart J. 2006 Jan;27(1):35-41. Epub 2005 Oct 6.PMID: 16210309 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Five-year risk of developing clinical diabetes after first myocardial infarction; the FINAMI study.

    Pajunen P, Koukkunen H, Ketonen M, Jerkkola T, Immonen-Räihä P, Kärjä-Koskenkari P, Mähönen M, Niemelä M, Kuulasmaa K, Palomäki P, Mustonen J, Lehtonen A, Arstila M, Vuorenmaa T, Lehto S, Miettinen H, Juolevi A, Torppa J, Tuomilehto J, Kesäniemi YA, Pyörälä K, Salomaa V.

    Diabet Med. 2005 Oct;22(10):1334-7.PMID: 16176192 [PubMed - indexed for MEDLINE]Related articles

    25.

    European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force Of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts).

    De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, Ebrahim S, Faergeman O, Graham I, Mancia G, Manger Cats V, Orth-Gomér K, Perk J, Pyorälä K, Rodicio JL, Sans S, Sansoy V, Sechtem U, Silber S, Thomsene T, Wood D; European Association for the Study of Diabetes (EASD); International Diabetes Federation Europe (IDF-Europe); European Atherosclerosis Society (EAS); European Heart Network (EHN); European Society of Caridiology (ESC); European Society of Hypertension (ESH); International Society of Behavioural Medicine (ISBM); European Society of General Practice/Family Medicine (ESGP/FM).

    Arch Mal Coeur Vaiss. 2004 Oct;97(10):1019-30. No abstract available. PMID: 16008181 [PubMed - indexed for MEDLINE]Related articles

    26.

    A new definition for myocardial infarction: what difference does it make?

    Salomaa V, Koukkunen H, Ketonen M, Immonen-Räihä P, Kärjä-Koskenkari P, Mustonen J, Lehto S, Torppa J, Lehtonen A, Tuomilehto J, Kesäniemi YA, Pyörälä K.

    Eur Heart J. 2005 Sep;26(17):1719-25. Epub 2005 Apr 6.PMID: 15814567 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    The validity of the Finnish Hospital Discharge Register and Causes of Death Register data on coronary heart disease.

    Pajunen P, Koukkunen H, Ketonen M, Jerkkola T, Immonen-Räihä P, Kärjä-Koskenkari P, Mähönen M, Niemelä M, Kuulasmaa K, Palomäki P, Mustonen J, Lehtonen A, Arstila M, Vuorenmaa T, Lehto S, Miettinen H, Torppa J, Tuomilehto J, Kesäniemi YA, Pyörälä K, Salomaa V.

    Eur J Cardiovasc Prev Rehabil. 2005 Apr;12(2):132-7.PMID: 15785298 [PubMed - indexed for MEDLINE]Related articles

    28.

    Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE Study.

    Balkau B, Hu G, Qiao Q, Tuomilehto J, Borch-Johnsen K, Pyörälä K; DECODE Study Group; European Diabetes Epidemiology Group.

    Diabetologia. 2004 Dec;47(12):2118-28. Epub 2004 Dec 15.PMID: 15662552 [PubMed - indexed for MEDLINE]Related articles

    29.

    [Spanish adaptation of the European guidelines on cardiovascular prevention (and II)]

    de Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, Ebrahim S, Faergemane O, Graham I, Mancia G, Manger Cats V, Orth-Gomér K, Perk J, Pyörälä K, Rodicio J, Sans S, Sansoy V, Sechtem U, Silber S, Thomsen T, Wood D; Tercer Grupo de Trabajo de las Sociedades Europeas y otras Sociedades Sobre la Prevención Cardiovascular en la Práctica Clínica.

    Aten Primaria. 2004 Nov 30;34(9):484-92. Spanish. No abstract available. PMID: 15563787 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Gender difference in the impact of type 2 diabetes on coronary heart disease risk.

    Juutilainen A, Kortelainen S, Lehto S, Rönnemaa T, Pyörälä K, Laakso M.

    Diabetes Care. 2004 Dec;27(12):2898-904.PMID: 15562204 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S). 1998.

    Pedersen TR, Olsson AG, Faergeman O, Kjekshus J, Wedel H, Berg K, Wilhelmsen L, Haghfelt T, Thorgeirsson G, Pyörälä K, Miettinen T, Christophersen B, Tobert JA, Musliner TA, Cook TJ; Scandinavian Simavastatin Survival Study Group.

    Atheroscler Suppl. 2004 Oct;5(3):99-106. No abstract available. PMID: 15531282 [PubMed - indexed for MEDLINE]Related articles

    32.

    Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994.

    Pedersen TR, Kjekshus J, Berg K, Haghfelt T, Faergeman O, Faergeman G, Pyörälä K, Miettinen T, Wilhelmsen L, Olsson AG, Wedel H; Scandinavian Simvastatin Survival Study Group.

    Atheroscler Suppl. 2004 Oct;5(3):81-7. No abstract available. PMID: 15531279 [PubMed - indexed for MEDLINE]Related articles

    33.

    The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart.

    Bartnik M, Rydén L, Ferrari R, Malmberg K, Pyörälä K, Simoons M, Standl E, Soler-Soler J, Ohrvik J; Euro Heart Survey Investigators.

    Eur Heart J. 2004 Nov;25(21):1880-90.PMID: 15522466 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    [European Guidelines on Cardiovascular Disease Prevention in the Clinical Practice. Third work group of the european societies and other societies on cardiovascular disease prevention in the clinical practice]

    de Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, Ebrahim S, Faergeman O, Graham I, Mancia G, Manger Cats V, Orth-Gomer K, Perk J, Pyorala K, Rodicio JL, Sans S, Sansoy V, Sechtem U, Silber S, Thomsen T, Wood D.

    Neurologia. 2004 Oct;19(8):440-50. Spanish. No abstract available. PMID: 15470585 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S).

    Strandberg TE, Pyörälä K, Cook TJ, Wilhelmsen L, Faergeman O, Thorgeirsson G, Pedersen TR, Kjekshus J; 4S Group.

    Lancet. 2004 Aug 28-Sep 3;364(9436):771-7.PMID: 15337403 [PubMed - indexed for MEDLINE]Related articles

    36.

    Plasma insulin and cardiovascular mortality in non-diabetic European men and women: a meta-analysis of data from eleven prospective studies.

    Hu G, Qiao Q, Tuomilehto J, Eliasson M, Feskens EJ, Pyörälä K; DECODE Insulin Study Group.

    Diabetologia. 2004 Jul;47(7):1245-56. Epub 2004 Jul 7.PMID: 15241592 [PubMed - indexed for MEDLINE]Related articles

    37.

    Risk factor management in diabetic and non-diabetic patients with coronary heart disease. Findings from the EUROASPIRE I AND II surveys.

    Pyörälä K, Lehto S, De Bacquer D, De Sutter J, Sans S, Keil U, Wood D, De Backer G; EUROASPIRE I Group; EUROASPIRE II Group.

    Diabetologia. 2004 Jul;47(7):1257-65. Epub 2004 Jul 2.PMID: 15235774 [PubMed - indexed for MEDLINE]Related articles

    38.

    Reduction of cardiovascular events by simvastatin in nondiabetic coronary heart disease patients with and without the metabolic syndrome: subgroup analyses of the Scandinavian Simvastatin Survival Study (4S).

    Pyörälä K, Ballantyne CM, Gumbiner B, Lee MW, Shah A, Davies MJ, Mitchel YB, Pedersen TR, Kjekshus J; Scandinavian Simvastatin Survival Study (4S).

    Diabetes Care. 2004 Jul;27(7):1735-40.PMID: 15220255 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts).

    De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, Ebrahim S, Faergeman O, Graham I, Mancia G, Cats VM, Orth-Gomér K, Perk J, Pyörälä K, Rodicio JL, Sans S, Sansoy V, Sechtem U, Silber S, Thomsen T, Wood D; European Society of Cardiology. American Heart Association. American College of Cardiology.

    Atherosclerosis. 2004 Apr;173(2):381-91. No abstract available. PMID: 15195638 [PubMed - indexed for MEDLINE]Related articles

    40.

    Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women.

    Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K; DECODE Study Group.

    Arch Intern Med. 2004 May 24;164(10):1066-76.PMID: 15159263 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Low-risk patients with chest pain and without evidence of myocardial infarction may be safely discharged from emergency department.

    Koukkunen H, Pyörälä K, O Halinen M.

    Eur Heart J. 2004 Feb;25(4):329-34.PMID: 14984922 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Overweight and obesity in patients with established coronary heart disease: are we meeting the challenge?

    De Bacquer D, De Backer G, Cokkinos D, Keil U, Montaye M, Ostör E, Pyörälä K, Sans S.

    Eur Heart J. 2004 Jan;25(2):121-8.PMID: 14720528 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).

    Girman CJ, Rhodes T, Mercuri M, Pyörälä K, Kjekshus J, Pedersen TR, Beere PA, Gotto AM, Clearfield M; 4S Group and the AFCAPS/TexCAPS Research Group.

    Am J Cardiol. 2004 Jan 15;93(2):136-41.PMID: 14715336 [PubMed - indexed for MEDLINE]Related articles

    44.

    European guidelines on cardiovascular disease and prevention in clinical practice.

    De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, Ebrahim S, Faergeman O, Graham I, Mancia G, Cats VM, Orth-Gomér K, Perk J, Pyörälä K, Rodicio JL, Sans S, Sansoy V, Sechtem U, Silber S, Thomsen T, Wood D; Third Joint Force of European and other Societies on Cardiovascular Disease and Prevention in Clinical Practice.

    Atherosclerosis. 2003 Nov;171(1):145-55. No abstract available. Corrected and republished in: Atherosclerosis. 2004 Apr;173(2):381-91. PMID: 14686332 [PubMed - indexed for MEDLINE]Related articles

    45.

    European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts).

    De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, Ebrahim S, Faergeman O, Graham I, Mancia G, Cats VM, Orth-Gomér K, Perk J, Pyörälä K, Rodicio JL, Sans S, Sansoy V, Sechtem U, Silber S, Thomsen T, Wood D; European Society of Cardiology Committee for Practice Guidelines.

    Eur J Cardiovasc Prev Rehabil. 2003 Aug;10(4):S1-S10.PMID: 14555889 [PubMed - indexed for MEDLINE]Related articles

    46.

    Predictive value of classical risk factors and their control in coronary patients: a follow-up of the EUROASPIRE I cohort.

    De Bacquer D, De Backer G, Ostör E, Simon J, Pyörälä K; EUROASPIRE I Study Group.

    Eur J Cardiovasc Prev Rehabil. 2003 Aug;10(4):289-95.PMID: 14555885 [PubMed - indexed for MEDLINE]Related articles

    47.

    Blood pressure is insufficiently controlled in European patients with established coronary heart disease.

    Boersma E, Keil U, De Bacquer D, De Backer G, Pyörälä K, Poldermans D, Leprotti C, Pilotto L, de Swart E, Deckers JW, Heidrich J, Sans S, Kotseva K, Wood D, Ambrosio GB; EUROASPIRE I and II Study Groups.

    J Hypertens. 2003 Oct;21(10):1831-40.PMID: 14508188 [PubMed - indexed for MEDLINE]Related articles

    48.

    European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.

    De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, Ebrahim S, Faergeman O, Graham I, Mancia G, Manger Cats V, Orth-Gomér K, Perk J, Pyörälä K, Rodicio JL, Sans S, Sansoy V, Sechtem U, Silber S, Thomsen T, Wood D; Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.

    Eur Heart J. 2003 Sep;24(17):1601-10. No abstract available. PMID: 12964575 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Decline in out-of-hospital coronary heart disease deaths has contributed the main part to the overall decline in coronary heart disease mortality rates among persons 35 to 64 years of age in Finland: the FINAMI study.

    Salomaa V, Ketonen M, Koukkunen H, Immonen-Räihä P, Jerkkola T, Kärjä-Koskenkari P, Mähönen M, Niemelä M, Kuulasmaa K, Palomäki P, Mustonen J, Arstila M, Vuorenmaa T, Lehtonen A, Lehto S, Miettinen H, Torppa J, Tuomilehto J, Kesäniemi YA, Pyörälä K.

    Circulation. 2003 Aug 12;108(6):691-6. Epub 2003 Jul 28.PMID: 12885751 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    n-3 Fatty acids and 5-y risks of death and cardiovascular disease events in patients with coronary artery disease.

    Erkkilä AT, Lehto S, Pyörälä K, Uusitupa MI.

    Am J Clin Nutr. 2003 Jul;78(1):65-71.PMID: 12816772 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...